Finance

Beta

Lists

Equity sectors
Symbols
Symbols
Trend
Change
Price
Change
% Change
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.45%
—
1,097.08
-0.45%
1,097.08
-5.00
-0.45%
1,102.081,104.411,110.611,096.10——
SIXC
Communications
SIXC
Communications
SIXC
+0.27%
—
571.79
+0.27%
571.79
+1.56
+0.27%
570.23570.23576.23566.53——
SIXE
Energy
SIXE
Energy
SIXE
-1.69%
—
1,124.31
-1.69%
1,124.31
-19.27
-1.69%
1,143.581,137.641,137.641,113.91——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.72%
—
1,820.63
+0.72%
1,820.63
+12.95
+0.72%
1,807.681,814.861,840.041,814.86——
SIXM
Financials
SIXM
Financials
SIXM
-0.91%
—
658.84
-0.91%
658.84
-6.03
-0.91%
664.87667.28670.86657.59——
SIXR
Staples
SIXR
Staples
SIXR
-0.49%
—
837.82
-0.49%
837.82
-4.10
-0.49%
841.92841.46843.77836.31——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.29%
—
214.08
-0.29%
214.08
-0.63
-0.29%
214.71214.71216.26213.98——
SIXT
Technology
SIXT
Technology
SIXT
+3.08%
—
3,853.63
+3.08%
3,853.63
+115.02
+3.08%
3,738.613,823.543,863.533,812.59——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.66%
—
901.60
+0.66%
901.60
+5.88
+0.66%
895.72896.48913.11896.48——
SIXV
Health care
SIXV
Health care
SIXV
-0.85%
—
1,505.60
-0.85%
1,505.60
-12.95
-0.85%
1,518.551,520.111,520.981,499.19——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.51%
—
2,365.50
+1.51%
2,365.50
+35.08
+1.51%
2,330.422,343.432,374.422,332.21——
LXEO:NASDAQ
Lexeo Therapeutics Inc
$4.93
-1.00%
(-0.050) Today
Closed: Jun 18, 4:00:01 PM GMT-4  ·   USD
$4.93
0.00% (0.00)
After hours  ·  4:03 PM
SymbolPriceChange% ChangePrev Close
Generating top insights for LXEO...
Open
$4.99
High
$5.34
Low
$4.92
Mkt. cap
387.11M
Avg. vol.
810.86K
Volume
1.48M
52-wk high
$10.99
52-wk low
$3.60
EPS
-$1.45
Shares outstanding
78.52M
No. of employees
59
Open
$4.99
High
$5.34
Low
$4.92
Mkt. cap
387.11M
Avg. vol.
810.86K
Volume
1.48M
52-wk high
$10.99
52-wk low
$3.60
EPS
-$1.45
Shares outstanding
78.52M
No. of employees
59
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to LXEO in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for LXEO in the last 3 months.
Highest
Current $4.93
$20.00 (+305.68%)
Average
$18.60 (+277.28%)
Lowest
$17.00 (+244.83%)
News stories
From sources across the web
Barchart.com
Barchart.com
·
1 hour ago
Is Snap-On Stock Underperforming the S&P 500?
Insider Monkey
Insider Monkey
·
9 hours ago
Is nCino (NCNO) One Of The Stocks Under $20 That Will Explode?
Seeking Alpha
Seeking Alpha
·
1 hour ago
S&P 500 Snapshot: Peace Deal Overcomes Fed Jitters
AP News
AP News
·
2 days ago
Stocks rise on Wall Street, erasing much of their loss from a day earlier
The Motley Fool
The Motley Fool
·
9 hours ago
The Vanguard S&P 500 ETF (VOO) Is the Most Popular ETF in the World. Here's One I Like Even Better.
Simply Wall Street
Simply Wall Street
·
4 hours ago
Is Multi‑Index S&P Inclusion Altering The Investment Case For First Advantage (FA)?
Yahoo Finance
Yahoo Finance
·
1 day ago
The Stock Market Is Doing Something Not Witnessed Since the Dot-Com Bubble. Here's What History Says Comes Next.
24/7 Wall St.
24/7 Wall St.
·
15 hours ago
This Space Stock Will Beat SpaceX to the Nasdaq-100 — And It’s the One to Buy
GuruFocus
GuruFocus
·
15 hours ago
Charles Schwab (SCHW) Launches New Yes-or-No Options Tied to S&P 500
TheStreet
TheStreet
·
13 hours ago
Wells Fargo new S&P 500 target sends investors clear signal
CoinDesk
CoinDesk
·
3 days ago
Forget the price charts. Here's how bitcoin and S&P 500 look like when adjusted for the money printer
CNN
CNN
·
2 weeks ago
Nasdaq, S&P 500 suffer worst day of year as AI stocks tumble and Fed rate-hike odds rise
Show more
About Lexeo Therapeutics Inc
CEO-
Employees59
Founded2017
Headquarters-
SectorBiotechnology
Websitelexeotx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
14.72M
15.70M
16.21M
15.70M
Cost of revenue
14.72M
15.70M
16.21M
15.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.97M
5.95M
6.91M
6.63M
Operating expense
15.97M
5.95M
6.91M
6.63M
Total operating expenses
30.69M
21.65M
23.12M
22.33M
Operating income
-30.69M
-21.65M
-23.12M
-22.33M
Other non operating income
-14.00K
-9.00K
9.00K
-1.00K
EBT including unusual items
-26.10M
-20.28M
-20.92M
-20.20M
EBT excluding unusual items
-29.46M
-20.22M
-20.91M
-20.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.10M
-20.28M
-20.92M
-20.20M
Net profit margin
-
-
-
-
Earnings per share
-0.68
-0.33
-0.27
-0.25
Interest and investment income
1.27M
1.46M
2.21M
2.11M
Interest expense
-25.00K
-22.00K
-20.00K
-17.00K
Net interest expenses
1.24M
1.43M
2.19M
2.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.55M
-21.50M
-22.96M
-22.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer